Science & Technology
Development of CIL-0X: A Platform to Enhance Delivery of Inhaled RNA Therapeutics to Lung Cells
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R43TR005938-01
Award Ceiling
$380K
Award Floor
$380K
Close Date
Jul 31, 2026
138 days leftTotal Funding
$380K
Expected Awards
1
Posted Date
Aug 1, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-1R43TR005938-01
Description
SBIR Phase Phase I award: "Development of CIL-0X: A Platform to Enhance Delivery of Inhaled RNA Therapeutics to Lung Cells" awarded to CILA THERAPEUTICS INC. in JAMAICA PLAIN, Massachusetts. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $379,948. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, Socially/economically disadvantaged, Women-owned businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.